Sepofarsen

sepofarsen · ProQR Therapeutics

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Sepofarsen, covering 2022-03-17 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION) [Phase 3]